Login / Signup

Survival Benefit for Patients With Metastatic Urothelial Carcinoma Receiving Continuous Maintenance Chemotherapy.

Chuang-Chi LiawTzu-Yao LiaoKe-Hung TsuiYu-Hsiang Juan
Published in: In vivo (Athens, Greece) (2019)
Continuous maintenance chemotherapy targeting chemo-sensitive tumors, administered at metronomic intervals and focus on tumor microenvironment, can increase MUC survival benefits.
Keyphrases
  • locally advanced
  • cancer therapy
  • free survival
  • photodynamic therapy
  • rectal cancer
  • radiation therapy
  • drug delivery
  • chemotherapy induced